Effects of colestipol hydrochloride (U-26,597A) on serum and fecal lipids in dogs
- 30 April 1973
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 17 (2), 167-179
- https://doi.org/10.1016/0021-9150(73)90086-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Efficacy and Safety of Cholestyramine Therapy in Hyperlipidemic Patients.Annals of Internal Medicine, 1971
- Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and manAtherosclerosis, 1970
- Safe Uses of CholestyramineAnnals of Internal Medicine, 1970
- Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patientJCI Insight, 1968
- The gas—liquid chromatography of dimethylsilyl, trimethylsilyl and chloromethyldimethylsilyl ethers of steroidsJournal of Chromatography A, 1967
- Cholestyramine in DogsJournal of Pharmaceutical Sciences, 1965
- Quantitative analysis of fecal bile acids by gas-liquid chromatographyAnalytical Biochemistry, 1963
- A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counterAnalytical Biochemistry, 1960
- Excretion of bile acids and β-hydroxysterols by ratsArchives of Biochemistry and Biophysics, 1958
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955